Ilumina Clinical Assoc LLC is categorized under Research Services in Johnstown, PA .
Ilumina Clinical Assoc LLC was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Research Services business, which does work in the B2B market, and is classified as a Research Services, under code number 5419100 by the NAICS.
If you are seeking more information, feel free to contact Sharon Barto, Chief Executive Officer at the company’s single location by writing to 136 Jaycee Drive # 5, Johnstown, Pennsylvania PA 15904 or by phoning (814) 467-4490. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ilumina Clinical Assoc LLC |
| Contact Person: | Sharon Barto, Chief Executive Officer |
| Address: | 136 Jaycee Drive # 5, Johnstown, Pennsylvania 15904 |
| Phone Number: | (814) 467-4490 |
| Website Address: | iluminaclinicals.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research Services |
| SIC Code: | 8732 |
| NAICS Code: | 5419100 |
| Share This Business: |
Ilumina Clinical Assoc LLC was started in 0 to provide professional Research Services under the SIC code 8732 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Sharon Barto, Chief Executive Officer for inquiries that concern Ilumina Clinical Assoc LLC by calling the company number (814) 467-4490, as your correspondence is most welcome. Additionally, the physical location of the single location of Ilumina Clinical Assoc LLC can be found at the coordinates 40.26061,-78.84762 as well as the street address 136 Jaycee Drive # 5 in Johnstown, Pennsylvania 15904.
For its online presence, you may visit Ilumina Clinical Assoc LLC’s website at iluminaclinicals.com and engage with its social media outlets through on Twitter and on Facebook.